People with congenital heart disease are seven times more likely to develop pulmonary hypertension than the general population, a long-term Danish…
Articles by Diogo Pinto
Patients with higher exercise capacity present a reduced risk of pulmonary arterial hypertension-associated death or hospitalization, according to results of…
Canada’s Quebec Province has agreed to provide public health insurance coverage of Actelion‘s pulmonary arterial hypertension therapy Uptravi (selexipag).